APA (7th ed.) Citation

P, O., A, S., E, F., H, A., A, B., A, L., . . . CA, P. (2026). Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma. Cancer research, 86(10), 2508. https://doi.org/10.1158/0008-5472.CAN-25-2985

Chicago Style (17th ed.) Citation

P, Odeniyide, et al. "Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma." Cancer Research 86, no. 10 (2026): 2508. https://doi.org/10.1158/0008-5472.CAN-25-2985.

MLA (9th ed.) Citation

P, Odeniyide, et al. "Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma." Cancer Research, vol. 86, no. 10, 2026, p. 2508, https://doi.org/10.1158/0008-5472.CAN-25-2985.